VIA EDGAR
June 21, 2021
U.S. Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4561
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Kasey Robinson |
Jeffrey Gabor |
| Re: | Monte Rosa Therapeutics, Inc. |
Acceleration Request for Registration Statement on Form S-1 |
File No. 333-256773 |
Requested Date: June 23, 2021 |
Requested Time: 4:00 p.m. Eastern Time |
Dear Ms. Robinson and Mr. Gabor:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), J.P. Morgan Securities LLC, Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters, hereby join Monte Rosa Therapeutics, Inc. in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-256773) (the “Registration Statement”) to become effective on June 23, 2021, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We advise that we have complied and will continue to comply, and that we have been informed by the participating underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.
[Signature Page Follows]
| Very truly yours, | ||
| J.P. MORGAN SECURITIES LLC | ||
| By: | /s/ David Ke | |
Name: David Ke Title: Managing Director | ||
| COWEN AND COMPANY, LLC | ||
| By: | /s/ Bill Follis | |
Name: Bill Follis Title: Managing Director | ||
| PIPER SANDLER & CO. | ||
| By: | /s/ Neil Riley | |
Name: Neil Riley Title: Head of Syndicate, Equity Capital Markets | ||
[Signature Page to Acceleration Request]
